References
- Petkau A. Scientific basis for the clinical use of su-peroxide dismutase. Cancer Treatment Rev. 1986; 13: 17
- Petkau A. Superoxide Dismutase, L. W. Ob-erley, 1985; vol. 3: 99
- Flohe L. Superoxide dismutase for therapeutic use: Clinical experience, dead ends and hops. Molecul. Cellul. Biochem. 1988; 84: 123
- Gorecki M., Beck Y., Hartman J. R., Fisher M., Weiss L., Tochner Z., Slavin S., Nimrod A. Recombinant human Superoxide dismutases: Production and potential therapeutical uses. Free Radical Res. Comm. 1991; 12–13: 401–410
- Hzuka H., Ishida A., Yamamoto A., Kajita S., Tsutsui M., Ohkuma N. Effects of UVB irradiation on epidermal adenylate cyclase responses in vitro: its relation to sunbum cell formation. Arch. Dermatolog. Res. 1988; 280: 163–167
- Malaher K., Das R. M. The effect of Superoxide dismutase on the pathogenesis of radiation-induced pulmonary damage in the rat. Pharmaceut. Therapy 1988; 39: 327
- Malaher K., Das R. M. Effect of Superoxide dismutase on early radiation injury of lungs in rat. Molecul. Cellul. Biochem. 1988; 84: 141
- Toda K., Miachi Y., Nesumi N., Konishi S., Ima-mara S. UVB/PUVA-induced suppression of human natural killer activity is reduced by superoxide dismutase and/ or interleukin 2 in vitro. J. Investig. Dermatol. 1986; 86: 519–522
- Petkau A. Protection of post-irradiated mice by superoxide dismutase. Int. J. Rad. Biol. 1976; 29: 297
- Petkau A. Protection of bone marrow progenitor cells by superoxide dismutase. Molecul. Cellul. Biochem. 1988; 84: 133